Two cancer research teams at
Cincinnati Children's Hospital were awarded a total of $2.3 million in National Institute of Health funding to continue studies that could lead to new treatments for leukemia and bone marrow failure.
One team, lead by Cincinnati Children's Drs. Yi Zheng and James Mulloy, will use its $1.04 million in funds for Leukemia Stem Cell research. Their work aims to develop a new treatment for leukemia stem cells in bone marrow for leukemia that is resistant to traditional chemotherapies.
Another team lead by Dr. Qishen Pang will use its $1.25 million award for a project studying bone marrow failure, once referred to as pre-leukemia. The work's goal is to find, prevent or better treat bone marrow failure and related cancer progression.
The researchers are part of the hospital's Cancer and Blood Diseases Institute at Cincinnati Children's and its divisions of Experimental Hematology/Cancer Biology and Hematology & Oncology.
Cincinnati Children's Hospital is one of the top two recipients of research grants from the NIH, and is one of 10 children's hospitals named to the Honor Roll in U.S. News and World Report's 2009-10 America's Best Children’s Hospitals.
Writer: Feoshia Henderson
Source: Cincinnati Children's Hospital Communications
Photography by Scott BeselerYou can follow Feoshia on twitter
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.